Key result
ACURATE neo valve linked to low rates of mortality, paravalvular leak, and pacemaker need.
Why the study?
The expansion of TAVI devices for severe symptomatic aortic stenosis necessitates evaluation of the ACURATE neo transcatheter aortic valve system.
The ACURATE neo transcatheter aortic valve system shows promising results in observational studies with low rates of complications, pending randomized trial data.
No takes yet. Share an insight, caveat, or question.
Promising observational results for ACURATE neo warrant randomized evaluation; should not yet change TAVR practice.
Choudhury et al. (2018) conducted a review in Severe symptomatic aortic stenosis. ACURATE neo transcatheter aortic valve system was evaluated. Observational data suggest the ACURATE neo transcatheter aortic valve system is associated with low rates of all-cause mortality, paravalvular leak, and permanent pacemaker requirement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: